Manufacturer record

Neutec Healthcare Pvt. Ltd. E-698: regulatory record

Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories

4 batches manufactured by Neutec Healthcare Pvt. Ltd. E-698 (Delhi) were declared Not of Standard Quality between August 2019 and April 2020. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.

Records by type

4 records linked to Neutec Healthcare Pvt. Ltd. E-698 in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.

0Banned or prohibited
0Recalled or suspended
4Failed a lab test
0Regulatory notice
Primary government sourceTier 1: government primary source

CDSCO drug alerts: Not of Standard Quality and spurious drugs

CDSCO · CDSCO monthly NSQ alerts, Aug 2019 to Apr 2020

View original document

Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.

4
NSQ batches since 2019
4
Products affected
Dissolution
Most common failure
Apr 2020
Latest alert

Flagged batches per year

2019 · 12020 · 3

All flagged batches

Product Batch Reason declared NSQ Tested by Alert
Dicyclomine Hydrochloride Tablets I.P.(Bargan) NT-17300Mfg 2017-09 · Exp 2020-08 AssayAssay RDTL GuwahatiState lab Apr 2020
Ciprofloxacin & Tinidazole Tablets (CIPROTEC-TZ) CTZ-19001Mfg 2019-08 · Exp 2022-07 DisintegrationDisintegration RDTL GuwahatiState lab Mar 2020
Metronidazole Tablets I.P. 400mg. (NEUZOL- 400) NZL-19002Mfg 2019-05 · Exp 2022-04 DissolutionDissolution RDTL GuwahatiState lab Feb 2020
Norfloxacin Tablets I.P. 400 mg (NORTEC-400) NTK-18004Mfg 2019-03 · Exp 2022-02 DissolutionDissolution RDTL GuwahatiState lab Aug 2019

Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.